After FDA delay, Sanofi scores subcutaneous OBI nod for Sarclisa
Sanofi has scored FDA approval for its subcutaneous version of Sarclisa, giving the multiple myeloma treatment a potential…
Global Cosmetics News – Weekly Review | Week 31, August 2026
This week, the global cosmetics and personal care industry highlighted the growing convergence of strong financial performance, strategic…
Zacks Industry Outlook Highlights Eli Lilly, Johnson & Johnson, Sanofi and Bayer
For Immediate Release Chicago, IL – March 3, 2026 – Today, Zacks Equity Research discusses Eli Lilly LLY,…